EarningsIEG reported a positive set of 2Q25 results, broadly in line with expectations at all levels.
Growth StrategyThe company confirmed its aim of consolidating growth further, fully counteracting the biennial effect.
ValuationThe stock remains significantly undervalued relative to peers: trading at a -44% discount on EV/EBITDA 2025E, -47% on EV/EBIT, and over -40% on P/E vs. the average of European comps.